Navigation Links
Hepatitis B Foundation to Host Annual Crystal Ball Gala
Date:1/14/2014

Doylestown, PA (PRWEB) January 14, 2014

Date: Friday, April 11, 2014

Time: 6 p.m. – 11 p.m.

Location: Warrington Country Club, 1360 Almshouse Road, Warrington, Pa.

Details: The Hepatitis B Foundation, the only national nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide, will host its annual Crystal Ball on Friday, April 11 at Warrington Country Club in Warrington, Pa.

Each year, the Crystal Ball attracts hundreds of leaders from the community, academic institutions, government, health care industry and biotech executives. The gala evening is a fundraiser for the foundation, with all proceeds benefitting its global research, outreach and patient advocacy programs.

This year’s event, the “Cherry Blossom Extravaganza,” includes an evening of dinner, dancing, a silent auction and awards ceremony. The Foundation will honor Dr. Thomas Starzl with the 2014 Baruch S. Blumberg Prize for pioneering the first human liver transplant in 1963.

Foundation leaders also will announce the recipients of the 2014 Community Commitment Award, Teri and Jim Holton, of Doylestown. Both have provided generous support to the Hepatitis B Foundation with Teri serving as chair of the Crystal Ball auction committee for the past four years and making it a tremendous success. In addition, Teri volunteers regularly in the community and her church and Jim supports many local food pantries with donations from Kellogg where he is a senior vice president.

The Hepatitis B Foundation is accepting auction items and sponsorship opportunities are still available. For more information regarding the Crystal Ball, call 215-489-4900.

About the Hepatitis B Foundation: Headquartered in Doylestown, Pa., the Hepatitis B Foundation is the only national nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. To learn more, go to http://www.hepb.org, read our blog at http://wp.hepb.org, follow us on Twitter @HepBFoundation, find us on Facebook at http://www.facebook.com/hepbfoundation or call 215-489-4900.

Contact: Sarah Larson at sarah(at)furiarubel(dot)com or 215-340-0480

Read the full story at http://www.prweb.com/releases/2014/01/prweb11488785.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Study: Higher Hepatitis C Infection During Acupuncture in Asian Americans; polyDNA Recommends That Doctors Prescribe Gene-Eden-VIR against HCV
2. FDA Advisory Committee Recommends Approval of Simeprevir for Combination Treatment of Genotype 1 Chronic Hepatitis C in Adult Patients
3. EU Should Better Prevent Citizens From Hepatitis, Says Liver Patients Organisation ELPA
4. Flagship Biosciences Introduces a New Technique for Measuring Fibrosis in Nonalcoholic Steatohepatitis
5. The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments
6. SeraCare Introduces New Hepatitis C ACCUVERT Seroconversion Panels and Anti-Herpes ACCUSET Performance Panel
7. Benitec Selects University of California, San Diego as a Site for Phase I/II Clinical Trial of TT-034 in Patients with Hepatitis C Infections
8. Janssen Announces Data from Simeprevir in Hepatitis C Patients Will Be Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
9. Comprehensive Global Testing Solutions for Novel Hepatitis C Therapeutics, New Webinar Hosted by Xtalks
10. A Phase IIa Interferon Free Combination Hepatitis C Trial of Simeprevir (TMC435) and TMC647055 Will Commence Shortly
11. Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 A person commits a crime, ... scene to track the criminal down. An outbreak ... and Drug Administration (FDA) uses DNA evidence to track down ... Sound far-fetched? It,s not. The FDA has increasingly used ... investigations of foodborne illnesses. Put as simply as possible, whole ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a ... discoveries to the medical community, has closed its Series ... Matthew Nunez . "We have received a ... the capital we need to meet our current goals," ... provide us the runway to complete validation on the ...
(Date:6/23/2016)... Windsor, Connecticut (PRWEB) , ... June 23, 2016 ... ... will introduce a new line of intelligent tools designed, tuned and optimized exclusively ... place September 12–17 in Chicago. The result of a collaboration among several companies ...
Breaking Biology Technology:
(Date:6/15/2016)... York , June 15, 2016 ... new market report titled "Gesture Recognition Market by Application ... Forecast, 2016 - 2024". According to the report, the  ... 11.60 billion in 2015 and is estimated to ... USD 48.56 billion by 2024.  Increasing ...
(Date:6/2/2016)... -- The Department of Transport Management (DOTM) of ... US Dollar project, for the , Supply and ... and IT Infrastructure , to Decatur ... of Identity Management Solutions. Numerous renowned international vendors participated in ... was selected for the most compliant and innovative solution. ...
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
Breaking Biology News(10 mins):